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Abstract
Background: Graphical displays of results allow researchers to summarise and communicate the
key findings of their study. Diagnostic information should be presented in an easily interpretable
way, which conveys both test characteristics (diagnostic accuracy) and the potential for use in
clinical practice (predictive value).
Methods: We discuss the types of graphical display commonly encountered in primary diagnostic
accuracy studies and systematic reviews of such studies, and systematically review the use of
graphical displays in recent diagnostic primary studies and systematic reviews.
Results: We identified 57 primary studies and 49 systematic reviews. Fifty-six percent of primary
studies and 53% of systematic reviews used graphical displays to present results. Dot-plot or box-
and- whisker plots were the most commonly used graph in primary studies and were included in
22 (39%) studies. ROC plots were the most common type of plot included in systematic reviews
and were included in 22 (45%) reviews. One primary study and five systematic reviews included a
probability-modifying plot.
Conclusion: Graphical displays are currently underused in primary diagnostic accuracy studies and
systematic reviews of such studies. Diagnostic accuracy studies need to include multiple types of
graphic in order to provide both a detailed overview of the results (diagnostic accuracy) and to
communicate information that can be used to inform clinical practice (predictive value). Work is
required to improve graphical displays, to better communicate the utility of a test in clinical practice
and the implications of test results for individual patients.
Background
Readers of a research report evaluating a diagnostic test
may wish to assess the test's characteristics (diagnostic
accuracy) or evaluate the impact that its use has on diag-
nostic decisions (predictive value) for individual patients.
Graphical displays of results of test accuracy studies allow
researchers to summarise and communicate the key find-
ings of their study. We discuss the types of graphical dis-
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accuracy studies and systematic reviews of such studies,
and systematically review the use of graphical displays in
recent diagnostic systematic reviews and primary studies.
Table 1 defines the various measures of diagnostic accu-
racy used.
Types of graphical display
Primary studies
Figure 1 illustrates four types of graphical display com-
monly used to present data on diagnostic accuracy for pri-
mary diagnostic accuracy studies. We used data from a
study of the biochemical tumour marker CA-19-9 antigen
to diagnose pancreatic cancer to construct these graphs
[1].
Dot plots (Figure 1a) and Box-and-whisker plots (Figure 1b)
Dot plots are used for test results that take many values,
and display the distribution of results in patients with and
without the target condition. Box and whisker plots sum-
marise these distributions: the central box covers the inter-
quartile range with the median indicated by the line
within the box. The whiskers extend either to the mini-
mum and maximum values or to the most extreme values
within 1.5 interquartile ranges of the quartiles, in which
case more extreme values are plotted individually [2].
Sometimes an indication of the threshold used to define a
positive test result is included, for example by adding a
horizontal line or shading at the relevant point. Such plots
can be used to clearly summarise a large volume of data,
but are only able to display differences in the distribution
of test values between patients with and without the target
condition; they do not directly display the diagnostic per-
formance of the test.
Although the CA-19-9 antigen test to diagnose pancreatic
cancer (used to construct Figure 1) is an example of con-
tinuous data, it is also possible to construct similar graphs
for categorical test results providing that the number of
categories is reasonably large. Alternatively, for smaller
numbers of categories, similar information can be con-
veyed using paired bar charts/histograms. Paired histo-
grams show the distribution of test results in patients with
the target condition above the x-axis and the distribution
in patients without the target condition below the x-axis.
These types of graphical display are less commonly used.
Table 1: Definitions of measures of diagnostic accuracy
Target condition
Present Absent
Test result + a b
- c d
Sensitivity a/(a + c) - Proportion of true positives that are correctly identified by the test [31]
Specificity d/(b + d) - Proportion of true negatives that are correctly identified by the test
Likelihood 
ratio (LR)
Describes how may times a person with disease is more likely to receive a particular test result than a person without disease 
[32] The interpretation of likelihood ratios depends very much on clinical context.
Likelihood ratio for positive result (LR +) = [a/(a + c)]/[b/(b + d)]
= sensitivity/(1 -specificity)
Likelihood ratio for negative result (LR -) = [c/(a + c)]/[d/(b + d)]
= (1 - sensitivity)/specificity
Diagnostic 
odds ratio 
(DOR)
Used as an overall (single indicator) measure of the diagnostic accuracy of a diagnostic test. It is calculated as the odds of 
positivity among diseased persons, divided by the odds of positivity among non-diseased. When a test provides no diagnostic 
evidence then the DOR is 1.0. [33] This measure has a number of limitations: by combining sensitivity and specificity into a single 
indicator the relative values of the two are lost i.e. the DOR can be the same for a very high sensitivity and low specificity as for 
very high specificity and low sensitivity [33] Further, tests that are effective for classifying persons as having or not having the 
target condition have DORs that whose magnitude is much greater (e.g. 100) than usually considered as indicating strong 
associations in epidemiological studies. [34]
DOR = [a/c]/ [b/d]
= [sensitivity/(1 -specificity)]/[(1 - sensitivity)/specificity]
= LR +ve/LR -ve
= ad/bc
Predictive 
value
Positive predictive value: proportion of patients with positive test results who are correctly diagnosed
Positive predictive value (PPV) = a/ (a + b)
Negative predictive value: proportion of patients with negative test results who are correctly diagnosed
Negative predictive value (NPV) = d (c + d)
Predictive values depend on disease prevalence, the more common a disease is, the more likely it is that a positive test result is 
right and a negative result is wrong. [35]Page 2 of 15
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dichotomous test results. However, truly dichotomous
tests rarely occur in practice. Examples of dichotomous
tests include dipstick tests that change colour if the target
condition is said to be present (although these are based
on an underlying implicit threshold) or the presence/
absence of certain clinical symptoms.
Receiver operating characteristic (ROC) plot (Figure 1c)
ROC plots show values of sensitivity and specificity at all
of the possible thresholds that could be used to define a
positive test result [3]. Typically, sensitivity (true positive
rate) is plotted against 1-specificity (false positive rate):
each point represents a different threshold in the same
group of patients. Stepped lines are used for continuous
Example graphical displays for primary study dataFigure 1
Example graphical displays for primary study data. a. Dot plot. b. Box-and-whisker plot. c. ROC Plot. d. Flow diagram.Page 3 of 15
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ries. ROC curves may be derived directly from the
observed sensitivity and specificity corresponding to dif-
ferent test thresholds, or by fitting curves based on para-
metric [4], semi-parametric [5,6], or non-parametric
methods [7]. The area under the ROC curve (AUC) is a sum-
mary of diagnostic performance, and takes values between
0.5 and 1. The more accurate the test, the more closely the
curve approaches the top left hand corner of the graph
(AUC = 1). A test that provides no diagnostic information
(AUC = 0.5) will produce a straight line from the bottom
left to the top right. ROC curves may be restricted to a
range of sensitivities or specificities of clinical interest.
ROC plots show how estimated sensitivity and specificity
vary according to the threshold chosen, and can be used
to identify suitable thresholds for clinical practice if the
points on the curve are labelled with the corresponding
threshold as in Figure 1c, which shows for example that
the sensitivity and specificity corresponding to a threshold
of 39.3 are 74% and 90%, respectively. Confidence inter-
vals can be added to indicate the uncertainty in estimates
of test performance at each point. ROC plots also allow
comparison of the performance of several tests independ-
ently of choice of threshold, by plotting data sets for mul-
tiple tests in the same ROC space. However, they are
thought to be difficult to interpret as they describe the
characteristics of the test in a way which does not relate
directly to its usefulness in clinical practice; research has
shown that ROC plots are generally poorly understood by
clinicians [8].
Flow charts (Figure 1d)
These depict the flow of patients through the study: for
example how many patients were eligible, how many
entered the study, how many of these had the target con-
dition, and the numbers testing positive and negative.
Such charts require categorisation of test results, for exam-
ple as "positive" and "negative". Although flow charts do
not directly present diagnostic accuracy data, addition of
percentages to the test result boxes (as in Figure 1d) can be
used to report test sensitivity (68/90 = 76%) and specifi-
city (46/51 = 90%). Charts that first separate individuals
according to test result before classification by disease sta-
tus may similarly be used to depict positive and negative
predictive values. The STARD (standards for reporting of
diagnostic accuracy) statement, an initiative to improve
the reporting of diagnostic test accuracy studies similar to
the CONSORT statement for clinical trials, recommends
the inclusion of a flow diagram in all reports of primary
diagnostic accuracy studies [9]. This should illustrate the
design of the study and provide information on the num-
bers of participants at each stage of the study as well as the
results of the study. The example flow chart in Figure 1d is
not a full STARD flow diagram as we do not have data on
numbers of withdrawals or uninterpretable results from
this study. It does, however, show the design (diagnostic
case-control) and results of the study.
Systematic reviews
Figure 2 illustrates two graphical displays commonly used
to present data on diagnostic accuracy in diagnostic sys-
tematic reviews. Data from a systematic review of dipstick
tests for urinary nitrite and leukocyte esterase to diagnose
urinary tract infections were used to construct these
graphs [10].
Forest plots (Figure 2a)
Forest plots are commonly used to display results of meta-
analysis. They display results from the individual studies
together with, optionally, a summary (pooled) estimate.
Point estimates are shown as dots or squares (sometimes
sized according to precision or sample size) and confi-
dence intervals as horizontal lines [11]. The pooled esti-
mate is displayed as a diamond whose centre represents
the estimate and tips the confidence interval.
For diagnostic accuracy studies, measures of test perform-
ance (sensitivity, specificity, predictive values, likelihood
ratios or diagnostic odds ratio) are plotted on the horizon-
tal axis. Diagnostic test performance is often described by
pairs of summary statistics (e.g. sensitivity and specificity;
positive and negative likelihood ratios), and these are
depicted side-by-side. Between-study heterogeneity can
readily be assessed by visual examination. Results may be
sorted by one of a pair of test performance measures, usu-
ally that which is most important to the clinical applica-
tion of the test. A disadvantage of paired forest plots is that
they do not directly display the inverse association
between the two measures that commonly results from
variations in threshold between studies.
ROC plots and summary ROC (SROC) curves (Figure 2b)
ROC plots can be used to present the results of diagnostic
systematic reviews, but differ from those used in primary
studies as each point typically represents a separate study
or data set within a study (individual studies may contrib-
ute more than one point). A summary ROC (SROC) curve
can be estimated using one of several methods [12-15]
and quantifies test accuracy and the association between
sensitivity and specificity based on differences between
studies. As with forest plots, ROC plots provide an over-
view of the results of all included studies. However, unless
there are very few studies, it is not feasible to display con-
fidence intervals as the plot would become cluttered.
Results for several tests can be displayed on the same plot,
facilitating test comparisons. It is also possible to display
pooled estimates of sensitivity and specificity together
with associated confidence intervals or prediction regions.
ROC plots may also be used to investigate possible expla-Page 4 of 15
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studies, for example those arising from differences in
study quality. Figure 3 shows results for a recent review
that we conducted on the accuracy of magnetic resonance
imaging (MRI) for the diagnosis of multiple sclerosis
(MS) [16]. By using different symbols to illustrate studies
that did (diagnostic cohort studies) and did not (other
study designs) include an appropriate patient spectrum
we were able to show that studies that included an inap-
propriate patient spectrum grossly overestimated both
sensitivity and specificity.
Other plots
Various other graphical methods have been developed to
display the results of systematic reviews and meta-analy-
ses [17,18]. Although not generally developed specifically
for diagnostic test reviews these can be adapted to display
the results of such reviews. Funnel plots [19] and Gal-
braith plots [20] are often used to assess evidence for pub-
lication bias or small study effects in systematic reviews of
the effects of medical interventions assessed in rand-
omized controlled trials. However, their application to
systematic reviews of diagnostic test accuracy studies is
Example graphs for systematic review dataFigure 2
Example graphs for systematic review data. a. Paired forest plots of sensitivity and specificity for LE dipstick. b. ROC 
plot with SROC curves.Page 5 of 15
(page number not for citation purposes)
BMC Medical Research Methodology 2008, 8:20 http://www.biomedcentral.com/1471-2288/8/20problematic [20]. Diagnostic odds ratios are typically far
from 1, and it has been shown that, for data of this type,
sampling variation can lead to artefactual associations
between log odds ratios and their standard errors [21]. It
is therefore recommended that the effective sample size
funnel plot be used in reviews of test accuracy studies [20].
Predictive value
A number of graphical displays aim to put results of diag-
nostic test evaluations into clinical context, based either
on primary studies or systematic reviews. Two graphical
displays commonly used for this purpose are the likeli-
hood ratio nomogram (Figure 4a) and the probability-
modifying plot (Figure 4b). Each allows the reader to esti-
mate the post-test probability of the target condition in an
individual patient, based on a selected pre-test probabil-
ity. To use the likelihood ratio nomogram, the reader
needs an estimate of the likelihood ratios for the test. He
then draws a line through the appropriate likelihood ratio
on the central axis, intersecting the selected pre-test prob-
ability, to derive the post-test probability of disease. The
probability-modifying plot depicts separate curves for
positive and negative test results. The reader draws a verti-
cal line from the selected pre-test probability to the appro-
priate likelihood ratio line and then reads the post-test
probability off the vertical scale. Both graph types are
based on a single estimate of test accuracy (likelihood
ratio), although it is possible to plot separate curves on
the probability-modifying plot or lines on the nomogram
to depict confidence intervals around the estimated likeli-
hood ratios. Each assumes constant likelihood ratios
across the range of pre-test probabilities. However, this
assumption may be violated in practice [22], because pop-
ulations in which the test is used may have different spec-
trums of disease to those in which estimates of test
accuracy were derived.
Example graphs for interpreting diagnostic study resultFigure 4
Example graphs for interpreting diagnostic study 
result. a. Likelihood ratio nomogram. b. Probability modify-
ing plot.
Sensitivity plotted against specificity, separately for cohort studies and f r studies of other designs for MRI f  diagnosis of multiple sclerosisFigure 3
Sensitivity plotted against specificity, separately for cohort 
studies and for studies of other designs for MRI for diagnosis 
of multiple sclerosis.Page 6 of 15
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Methods
We systematically reviewed how graphical displays are
currently incorporated in studies of test performance. We
included primary diagnostic accuracy studies published in
2004, identified by hand searching 12 journals (Table 2),
and diagnostic systematic reviews published in 2003,
identified from DARE (Database of Abstracts of Reviews
of Effects) [23]. Searches were conducted in 2005 and so
these years were the most complete available years for
searching (there is a delay in adding studies to DARE).
Diagnostic accuracy studies were studies that provided
data on the sensitivity and specificity of a diagnostic test
and that focused on diagnostic (whether the patient had
the condition of interest) rather than prognostic (disease
severity/risk prediction) questions. Journals were selected
to provide a mixture of the major general medical and
specialty journals. We particularly aimed to select journals
that clinicians read. We extracted data on the different
graphical displays used to summarise information about
test performance, defined as any graphical method of
summarising data on diagnostic accuracy or the predictive
value of a test (Table 1).
We located 56 primary studies and 49 systematic reviews
(Web Appendix). Fifty-seven percent of primary studies
and 53% of systematic reviews used graphical displays to
present results. In publications using graphics, the
number of graphs per publication ranged from 1 to 51
(median 2, IQR 1 to 3 for primary studies and median 4,
IQR 2 to 7 for systematic reviews). Table 3 summarises the
categories of tests evaluated in the primary studies and
systematic reviews. None of the tests evaluated in any of
the primary studies were truly dichotomous: they all gave
continuous or categorical results. Three of the eight sys-
tematic reviews that assessed clinical examination looked
at whether a variety of signs or symptoms were present or
absent: these can be considered as truly dichotomous
tests. All other reviews evaluated continuous or categorical
tests.
Primary studies
Dot-plots or box-and-whisker plots were the most com-
monly used graphic and were included in 22 (39%) stud-
ies. Generally the plots showed individual test results
separately for patients with and without the target condi-
tion, with four including an indication of the threshold
used to define a positive test result. Three studies included
both a dot plot and a box-and-whisker plot on the same
figure. Other variations included separate plots for differ-
ent patient subgroups, different symbols to indicate differ-
ent stages of disease, or separate plots for different tests.
The majority of studies using these types of plots were of
laboratory tests. An ROC curve was displayed in 15 (26%)
studies. All of these plotted full ROC curves; only two pro-
vided any indication of the thresholds corresponding to
one or more of the points. Thirteen studies included sep-
arate ROC curves for different tests, either on the same
plot (10 studies) or on separate plots (3 studies). Five
studies included separate ROC plots for different patient
subgroups. Although all the primary studies were pub-
lished in 2004, after the publication of the STARD guide-
lines, only one included a STARD flow diagram.
Systematic reviews
ROC plots were included in 22 (45%) reviews. Twenty
showed individual study estimates of sensitivity and spe-
cificity, 14 fitted SROC curves, and two displayed a sum-
mary point. One study, which did not fit an SROC curve,
added a box and whisker plot to each axis to show the dis-
tributions of sensitivity and specificity. One study plotted
only summary estimates of sensitivity and specificity in
ROC space, with no SROC curves. Some reviews included
separate plots for different tests, for different patient sub-
groups, or for different thresholds used to define a posi-
tive test result.
Table 2: Number of primary studies identified from the journals searched together with the number of studies from each journal that 
included graphical displays
Journal Number of studies Number with graphs (%)
Clinical Chemistry 25 18 (72)
American Journal of Obstetrics and Gynecology 1 0 (0)
Annals of Internal Medicine 6 3 (50)
BMJ 3 0 (0)
European Journal of Pediatrics 1 0 (0)
Gastroenterology 7 4 (57)
JAMA 5 2 (40)
British Journal of Radiology 1 1 (100)
Lancet 3 2 (67)
New England Journal of medicine 3 2 (67)
Thorax 2 0Page 7 of 15
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study results. One study provided a plot of diagnostic
odds ratios, while all others displayed paired plots of sen-
sitivity and specificity (8 reviews), positive and negative
likelihood ratios (3 reviews), or positive and negative pre-
dictive values (1 review). Several studies displayed more
than one set of forest plots, including plots for more than
one summary measure, for different stages of diagnosis,
different test thresholds or for different tests. One study
included a forest plot of summary data only, showing
how pooled estimates of positive and negative likelihood
ratios varied for different patient subgroups.
Predictive value
None of the studies included a likelihood ratio nomo-
gram. One primary study and five systematic reviews
included a probability-modifying plot.
Discussion
Research in the area of cognitive psychology suggests that
sensitivity and specificity are generally poorly understood
by doctors [8,24] and are often confused with predictive
values [8,25,26]. Doctors tend to overestimate the impact
of a positive test result on the probability of disease
[27,28] and this overestimation increases with decreasing
pre-test probabilities of disease [29]. This research sug-
gests that the most informative measures for doctors may
be estimates of the post-test probability of disease (predic-
tive value), which can be presented as a range correspond-
ing to different pre-test probabilities. However, graphical
displays that facilitate the derivation of post-test probabil-
ities, such as likelihood ratio nomograms, are usually
based on summary estimates of test characteristics (posi-
tive and negative likelihood ratios) without allowing for
the precision of the estimate, or its applicability to a given
population. Use of summary estimates in this way is ques-
tionable in the context of reviews of diagnostic accuracy
studies, which typically find substantial between-study
heterogeneity [30]. It is particularly problematic if the
summary estimate is the only information conveyed in a
graphic and the graphic is taken as the key message of the
paper.
The inclusion of some form of graphical presentation of
test accuracy data has a number of advantages compared
to not using such displays. It allows fuller reporting of
results, for example (S)ROC plots can display results for
multiple thresholds whereas reporting test accuracy
results in a text or table generally requires the selection of
one or more thresholds. In addition, (S)ROC plots depict
the trade-off between sensitivity and specificity at differ-
ent thresholds. Use of such displays also have the advan-
tage of presenting all of the results of a primary study or
systematic review without the need for selected analyses,
which may be biased depending on the analyses selected.
The inclusion of graphical displays, such as SROC plots or
forest plots, in systematic reviews of test accuracy studies
allows a visual assessment of heterogeneity between stud-
ies by showing the results from each individual study
included in the review. There is also a suggestion that
graphical displays may be easier to interpret than text or
tabular summaries of the same data.
Diagnostic accuracy studies will usually need to include
more than one graphic in order both to provide a detailed
description of results (diagnostic accuracy) and to com-
municate appropriate summary measures that can be used
to inform clinical practice (predictive value); the more
detailed graphic provides context for the interpretation of
summary measures. Further work is required to improve
on existing graphical displays. The starting point for this
should be further evaluation of the types of graphical dis-
play most helpful to assessing the utility of a test in clini-
cal practice and the implications of test results for
individual patients.
We hope that this paper will contribute to an increase in
the use and quality of graphical displays in diagnostic
accuracy studies and systematic reviews of these studies.
To achieve this, journal guidelines and the STARD state-
ment need to encourage the use of graphs in reports of test
accuracy. Currently, journal guidelines say very little
about this issue. A brief review of the instructions for
authors from a selection of leading medical journals
(Annals of Internal Medicine, BMJ, Clinical Chemistry, JAMA,
Lancet, New England Journal of Medicine) found that these
only provide formatting guidelines rather than discussing
when and what type of graphical displays should be used,
although all except the New England Journal of Medicine
recommend that the STARD guidelines be followed and
Table 3: Number of studies evaluating each category of tests in the primary studies and systematic reviews.
Test category Number of primary studies Number of systematic reviews
Clinical examination 4 8
Imaging 13 22
Laboratory 36 11
Questionnaires 0 3
Combination of different categories 3 4Page 8 of 15
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itself does not comment on how graphical displays
should be used to convey results of test accuracy studies
other than to recommend the inclusion of a flow diagram
and to provide an illustration of a dot-plot as a suggestion
for how individual study results may be displayed. Guide-
lines on the type of graphical displays that should be
included in reports of test accuracy studies could be con-
sidered when STARD is next updated, and should be con-
sidered by journals in their instructions for authors.
Conclusion
Our review suggests that graphical displays are currently
underused in primary diagnostic accuracy studies and sys-
tematic reviews of such studies. Graphical displays of
diagnostic accuracy data should provide an easily inter-
pretable and accurate representation of study results, con-
veying both diagnostic accuracy and predictive value. This
is not usually possible in a single graphic: the type of
information presented in the most commonly used
graphs does not directly allow clinicians to assess the
implications of test results for an individual patient.
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